A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
4Moving Biotech · Knee Osteoarthritis · Synovitis of Knee
Phase 2
Active, not recruiting
129
2026-07
Industry sponsor intelligence
4Moving BiotechClinical Pipeline.
Lead-sponsor view of 4Moving Biotech's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 2
- Recruiting
- 0
- Active
- 1
- Completed
- 1
- Results posted
- 1
- Avg enrollment
- 82
Pipeline overview
Programs by phase and activity.
Velocity
4Moving Biotech trials by start year
Study start year · indexed snapshot
Development
Trials by phase
2phase labels
Early Phase 10
Phase 11
Phase 21
Phase 30
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Liraglutide → | 2 | 1 | 1 | 0 | 0 | 1 |
| Glucagon → | 1 | 0 | 1 | 0 | 0 | 1 |
Active peptide trials
In motion now.
NCT IDStudyPhase / statusEnrollmentUpdated
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee
4Moving Biotech · Knee Osteoarthritis
Phase 1
Completed
34
2025-06
Search sponsor records
All 4Moving Biotech studies.
This page groups studies where 4Moving Biotech is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
2 matching studies
Last registry update first
Recent updates